- Home
- DDI vs NKTR Comparison
DDI vs NKTR Comparison
Compare DDI & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDI
- NKTR
- Stock Information
- Founded
- DDI 2008
- NKTR 1990
- Country
- DDI South Korea
- NKTR United States
- Employees
- DDI N/A
- NKTR N/A
- Industry
- DDI EDP Services
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- DDI Technology
- NKTR Health Care
- Exchange
- DDI Nasdaq
- NKTR Nasdaq
- Market Cap
- DDI 472.2M
- NKTR 558.0M
- IPO Year
- DDI 2021
- NKTR 1994
- Fundamental
- Price
- DDI $9.38
- NKTR $49.46
- Analyst Decision
- DDI Strong Buy
- NKTR Strong Buy
- Analyst Count
- DDI 5
- NKTR 6
- Target Price
- DDI $19.60
- NKTR $81.67
- AVG Volume (30 Days)
- DDI 49.7K
- NKTR 1.1M
- Earning Date
- DDI 11-10-2025
- NKTR 11-06-2025
- Dividend Yield
- DDI N/A
- NKTR N/A
- EPS Growth
- DDI N/A
- NKTR N/A
- EPS
- DDI 2.15
- NKTR N/A
- Revenue
- DDI $333,256,000.00
- NKTR $74,934,000.00
- Revenue This Year
- DDI $16.04
- NKTR N/A
- Revenue Next Year
- DDI $6.72
- NKTR N/A
- P/E Ratio
- DDI $4.32
- NKTR N/A
- Revenue Growth
- DDI 0.24
- NKTR N/A
- 52 Week Low
- DDI $8.09
- NKTR $6.48
- 52 Week High
- DDI $18.21
- NKTR $50.53
- Technical
- Relative Strength Index (RSI)
- DDI 45.72
- NKTR 57.94
- Support Level
- DDI $9.20
- NKTR N/A
- Resistance Level
- DDI $9.74
- NKTR $50.53
- Average True Range (ATR)
- DDI 0.22
- NKTR 3.20
- MACD
- DDI -0.02
- NKTR -0.30
- Stochastic Oscillator
- DDI 19.15
- NKTR 98.58
About DDI DoubleDown Interactive Co. Ltd. American Depository Shares
DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. The company's operating segments include the social casino games segment and the iGaming segment. The company generates the majority of its revenue from social casino games. Geographically, the company generates the majority of its revenue from the United States.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.